TotalMarketCap

Jaguar Health

JAGXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$5.348 M

$0.40 -19.67%

Close of 6 Nov 2026

As of 6 Nov 2026, Jaguar Health (JAGX) has a market capitalization of $5.35M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$11.5M

#3101 by revenue

Earnings

-$54.0K

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #445LongeveronLGVN$5.52M
  2. #446Acurx PharmaceuticalsACXP$5.39M
  3. #447Jaguar HealthJAGX$5.35M
  4. #448PulmatrixPULM$5.31M
  5. #449Processa PharmaceuticalsPCSA$5.26M

What if Jaguar Health were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,115,758

Per share 5,280,154× higher

Bitcoin $1.53T

$114,479.96

Per share 285,700× higher

Apple $5.02T

$375,827.03

Per share 937,926× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Jaguar Health are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.